Pharmaceutical & Drug Manufacturers Pharmaceutical & Drug Manufacturers Pharmaceutical & Drug Manufacturers
BUSINESS DIRECTORY PRODUCT CATALOG PHARMACEUTICAL CATALOGS PHARMA TRADE LEADS EXPORT IMPORT POLICIES POLICIES & ORDERS

Home » Pharmaceutical Drugs » Pharmaceutical Finished Formulations » Injection »

Finished Formulations
Pharmaceutical Drugs

Glossary



CEFTRIAXONE


Ceftriaxone is an antibiotic belonging to the class of drugs called cephalosporins. It is used for fighting bacteria in the body. It treats different types of bacterial infections including Bronchitis, pneumonia, bone infections, abdominal and skin infections, urinary tract infections etc.

Ceftriaxone is available in injection form and can be administered either intravenously (into a vein) or intramuscularly (into a muscle).

Brand Name: Rocephin

Chemical description: (6R,7R,Z)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Dosage
Meningitis:
Adults: 4gm i.v. Initially followed by 2gm i.v. Once daily for ten days or 72 hours after fever abates.
Children: 75-100mg/kg body weight for 7-9 days

Typhoid:
Adults: 4 gm daily for 2 days followed by 2 gm daily for 2 days.
Children: 75 mg/kg body weight daily for 7 days.

Other Conditions:
Adults: 1-2 grams daily
Children: 50-75 mg/kg body weight daily

Contra- Indications: Hypersensitivity

Side Effects
The drug has certain side effects, that can affect individuals in different ways. The following are some of the side effects, that are often associated with the drug:
  • Diarrhoea
  • Nausea or vomiting
  • Blood or mucous in stool
  • Allergic reaction like rash
Pregnant and lactating women should use the drug with caution. Dose should be decreased in elderly people in case of renal impairment.

Disclaimer: The above information is for general understanding of the visitor. Please consult a registered medical practitioner before taking the aforesaid medicine.